Bamco Inc Inhibrx, Inc. Transaction History

Bamco Inc

  • $36.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$16.96 - $27.82 $212,000 - $347,750
-12,500 Reduced 29.41%
30,000 $778,000
Q1 2023

May 15, 2023
SELL
$18.45 - $27.14 $507,375 - $746,350
-27,500 Reduced 39.29%
42,500 $801,000
Q4 2022

Feb 14, 2023
BUY
$20.18 - $33.33 $1.41 Million - $2.33 Million
70,000 New
70,000 $1.72 Million

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $570M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email